As shown in Figure 5, the gastric cancer PDX models (0406022, A11068, 0501116, and A19058) expressed high (IHC 3+), moderate (IHC 2+), low (IHC 1+), and negative (IHC 0) levels of TROP2, respectively. This evidence concerns the gene TACSTD2 and gastric cancer.